Tue, Sep 16, 2014, 6:26 AM EDT - U.S. Markets open in 3 hrs 4 mins

Recent

% | $
Quotes you view appear here for quick access.

Curis, Inc. Message Board

bensjaca 4 posts  |  Last Activity: Feb 4, 2014 2:47 PM Member since: Apr 1, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • maybe US sales were not as robust as originally projected? Japan might be helpful to balance out. whatever it is the price action is rather strange and alarming for sure.

  • Reply to

    What?

    by irishman10167 Dec 9, 2013 11:45 AM
    bensjaca bensjaca Dec 9, 2013 1:15 PM Flag

    Hope what you said is true but just too much of a coincidence to be happening just when they released the initial ph1 results. Wonder whether they were expecting better results?? PR in 1/9 and SD in 7/9.

  • Reply to

    Maybe the shorts are exiting & this is why

    by whogo70 Sep 24, 2013 12:57 PM
    bensjaca bensjaca Sep 24, 2013 2:54 PM Flag

    really dont have answers to any of your questions. One thing is for sure, the chance for approval is high, we had been trading at 4.45, we were dropped and are being held at 4. So with approval the lowest possibility is 4.5. I personally dont want more (not greedy). If it goes higher then well and good. A crl/pushback could send it to 3.5 but even with that it will just prolong our hold till they resolve any issues since it is an approved drug and has been tried S/C with adequate safety/exposure/efficacy. I will most likely hold on till we hear anything about collaborations with major clients rather than rumors/speculations.

  • Reply to

    Up $.70

    by tdvn2007 Sep 24, 2013 2:36 PM
    bensjaca bensjaca Sep 24, 2013 2:41 PM Flag

    have the same question!! either way looks good. There is a decent volume too. Crept over 11 just now.

CRIS
1.58-0.03(-1.86%)Sep 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT